USV picks up a majority stake in Wellbeing Nutrition at ₹1,583 crore
USV will add Wellbeing Nutrition’s portfolio while planning for the GLP-1 therapy segment as semaglutide patents expire
USV will add Wellbeing Nutrition’s portfolio while planning for the GLP-1 therapy segment as semaglutide patents expire